interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development
EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).
The EU Clinical Trials Register currently displays
43881
clinical trials with a EudraCT protocol, of which
7295
are clinical trials conducted with subjects less than 18 years old.
The register also displays information on
18700
older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see
Frequently Asked Questions ).
4 result(s) found for: Dipalmitoylphosphatidylcholine.
Displaying page 1 of 1.
EudraCT Number: 2005-000489-37
Sponsor Protocol Number: SURF-04-01
Start Date*: 2005-08-26
Sponsor Name:Nektar Therapeutics
Full Title: An open label, randomized, controlled study to evaluate the safety and efficacy of aerosolized surfactant, Curosurf®, delivered via nasal continuous positive airway pressure pulmonary drug delivery...
Medical condition: The medical condition for this application is the Respiratory Distress Syndrome (RDS).
RDS, also known as hyaline membrane disease, is characterized by lung immaturity and surfactant deficiency a...
Disease:
Population Age: Preterm newborn infants, Newborns, Under 18
Full Title: A MULTINATIONAL, MULTICENTER, MASKED, RANDOMIZED, CONTROLLED
STUDY TO ASSESS THE SAFETY AND EFFICACY OF LUCINACTANT FOR
INHALATION IN PRETERM NEONATES 26 TO 32 WEEKS GESTATIONAL AGE
WITH RESPIRATOR...
Medical condition: Respiratory Distress Syndrome (RDS)
Disease:
Version
SOC Term
Classification Code
Term
Level
20.0
10038738 - Respiratory, thoracic and mediastinal disorders
10021735
Infant respiratory distress syndrome
LLT
20.0
10038738 - Respiratory, thoracic and mediastinal disorders
10038690
Respiratory distress syndrome (neonatal)
LLT
20.0
10038738 - Respiratory, thoracic and mediastinal disorders
Sponsor Name:Windtree Therapeutics, Inc. (formerly Discovery Laboratories, Inc.)
Full Title: A Multicenter, Randomized, Open-Label, Controlled Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Preterm Neonates 26 to 28 Weeks PMA.
Medical condition: Respiratory Distress Syndrome (RDS)
Disease:
Version
SOC Term
Classification Code
Term
Level
19.1
10038738 - Respiratory, thoracic and mediastinal disorders
10021735
Infant respiratory distress syndrome
LLT
19.1
10038738 - Respiratory, thoracic and mediastinal disorders
10038690
Respiratory distress syndrome (neonatal)
LLT
19.1
10038738 - Respiratory, thoracic and mediastinal disorders
Full Title: A Multinational, Multicenter, Masked, Randomized, Parallel Group, Controlled Study to Assess the Safety and Efficacy of Lucinactant for Inhalation versus nCPAP alone in Preterm Neonates 26 to 32 We...
Medical condition: Respiratory Distress Syndrome (RDS)
Disease:
Version
SOC Term
Classification Code
Term
Level
21.1
10038738 - Respiratory, thoracic and mediastinal disorders
10021735
Infant respiratory distress syndrome
LLT
21.1
10038738 - Respiratory, thoracic and mediastinal disorders
10038690
Respiratory distress syndrome (neonatal)
LLT
21.1
10038738 - Respiratory, thoracic and mediastinal disorders
Subscribe to this Search
To subscribe to the RSS feed for this search click
here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options:
Number of Trials to download:
Download Content:
Download Format:
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
• EEA CTAs: Date study was authorised to proceed • Outside EU/EEA: Date study was submitted in EudraCT